Plain-English translation of NCT03406247 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing two different approaches using immunotherapy drugs— alone, or combined with —to help prevent head and neck cancer from coming back after surgery. These medications work by helping your body's immune system recognize and fight cancer cells. The researchers believe this approach may work as well as traditional radiation therapy but with fewer serious side effects.
When head and neck cancer comes back in an area that was already treated with radiation, doctors have traditionally given more radiation therapy after surgery. However, this medication is being tested because it might offer similar protection against cancer returning while potentially causing less harm to healthy tissues.
You likely qualify if…
You likely don't qualify if…
You will be assigned randomly to receive either the medication alone or the medication in combination with a second drug. Treatment lasts 6 months total, given as injections every 2 to 4 weeks depending on your assigned group. You will have regular visits to the hospital or clinic for your injections and blood tests to monitor how you're responding and to watch for any side effects. The study team will follow you closely throughout and after treatment to see whether the cancer stays away.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France